世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Temperature Controlled Pharmaceutical Packaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Temperature Controlled Pharmaceutical Packaging was estimated to be worth US$ 6409 million in 2025 and is projected to reach US$ 10390 million, growing at a CAGR of 7.2% from ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Temperature Controlled Pharmaceutical Packaging was estimated to be worth US$ 6409 million in 2025 and is projected to reach US$ 10390 million, growing at a CAGR of 7.2% from 2026 to 2032.The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Temperature Controlled Pharmaceutical Packaging cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations. Temperature-controlled Pharmaceutical Packaging refers to specialized packaging systems designed to maintain stable temperature ranges for temperature-sensitive products such as pharmaceuticals, vaccines, biologics, and cell and gene therapy materials during transportation, storage, and last-mile delivery. Its core purpose is to safeguard product integrity and therapeutic efficacy amid fluctuating external environments and complex logistics processes. These systems typically combine insulation materials, phase-change materials (PCMs), monitoring devices, and engineered packaging structures to achieve controlled conditions across ranges such as 2–8°C, 15–25°C, frozen, and ultra-low temperatures. With the rapid expansion of biopharmaceuticals, vaccines, cell therapies, blood products, and other thermosensitive formulations, temperature-controlled packaging is evolving from conventional insulated boxes toward high-performance materials, digital monitoring, and end-to-end traceable solutions, becoming a critical pillar of pharmaceutical supply-chain resilience.In 2024, global Temperature-controlled Pharmaceutical Packaging production reached approximately 124.75 m units , with an average global market price of around US$ 47.9 perunit.The average gross profit margin of this product is 22%. The rapid expansion of global biopharmaceuticals continues to create strong, sustained demand for temperature-controlled pharmaceutical packaging. Growth in vaccines, antibody drugs, cell and gene therapies, blood products, and temperature-sensitive formulations requires more robust and consistent temperature management throughout logistics chains. Annual reports and government supply-chain initiatives highlight rising expectations for temperature stability in distribution, driving pharmaceutical companies and logistics providers to upgrade to higher-performance packaging systems. Cross-border trials, e-commerce pharmacies, and global product flow further increase usage frequency. As regulators tighten transportation requirements, products offering higher precision, traceability, and validated performance are becoming primary drivers of industry growth. Despite strong momentum, the sector faces intensified competition and cost pressure. Industry leaders report margin challenges due to raw-material volatility, energy costs, and global supply-chain disruptions. Stricter regulatory standards for temperature validation and transportation quality require increased investment in compliance testing, material stability studies, and validation management. Growing customer specialization—such as customized solutions for various drug types and transport routes—raises operational complexity. Meanwhile, competition expands beyond traditional insulated-box manufacturers to include advanced-materials companies and cold-chain technology providers. Downstream stakeholders are shifting from regulatory compliance to proactive quality and efficiency enhancement. Stability verification and full-chain visibility are increasingly prioritized, making monitoring-enabled, data-integrated packaging more desirable. As biologics gain share, demand extends beyond insulation performance toward lightweighting, reusability, intelligence, and sustainability. Cross-border drug transport and global clinical trials introduce diverse logistics scenarios, accelerating adoption of combined high-performance passive and active solutions. Overall, downstream demand is shifting toward safer, more traceable, more efficient, and greener packaging systems. Key upstream components include EPS, PU, and VIP insulation materials, phase-change materials, composite films, monitoring modules, and engineered structures. Annual reports indicate continuous advancement toward lower thermal conductivity, higher insulation efficiency, and reduced weight, while government support for sustainable materials accelerates green alternatives. Policy-driven localization further strengthens domestic development of sensors, monitoring electronics, and smart modules. With higher temperature-control requirements, upstream suppliers increasingly collaborate with system integrators in validation and performance testing, shifting the value chain from material supply to co-development and integrated solution capability. This report provides a comprehensive view of the global market for Temperature Controlled Pharmaceutical Packaging, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application. The Temperature Controlled Pharmaceutical Packaging market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Temperature Controlled Pharmaceutical Packaging. Market Segmentation By Company ThermoSafe Envirotainer Pelican Biothermal Cryopak DS Smith Pharma Cold Chain Technologies Intelsius CSafe World Courier Sofrigam SA Ltd. American Aerogel Corporation Aeris Group Inmark Packaging Saixin Cold Chain CIMC Cold Cloud Minsate Beijing Youleng Cold Chain Segment by Type EPS material PU material VIP material Segment by Usage Mode Single use Reusable Other Segment by Target Temperature 2–8°C Cold Chain 15–25°C Controlled Ambient Segment by Application Biopharmaceuticals Vaccines Others By Region North America Europe China Japan Consumption by Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications. Chapter 2: Provides a detailed analysis of the Temperature Controlled Pharmaceutical Packaging manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A). Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities. Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities. Chapter 5: Presents Temperature Controlled Pharmaceutical Packaging sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide. Chapter 6: Presents Temperature Controlled Pharmaceutical Packaging sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region. Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc. Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Temperature Controlled Pharmaceutical Packaging Product Introduction 1.2 Global Temperature Controlled Pharmaceutical Packaging Market Size Forecast 1.2.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value (2021–2032) 1.2.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume (2021–2032) 1.2.3 Global Temperature Controlled Pharmaceutical Packaging Sales Price (2021–2032) 1.3 Temperature Controlled Pharmaceutical Packaging Market Trends & Drivers 1.3.1 Temperature Controlled Pharmaceutical Packaging Industry Trends 1.3.2 Temperature Controlled Pharmaceutical Packaging Market Drivers & Opportunities 1.3.3 Temperature Controlled Pharmaceutical Packaging Market Challenges 1.3.4 Temperature Controlled Pharmaceutical Packaging Market Restraints 1.3.5 Impact of U.S. Tariffs 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Temperature Controlled Pharmaceutical Packaging Players Revenue Ranking (2025) 2.2 Global Temperature Controlled Pharmaceutical Packaging Revenue by Company (2021–2026) 2.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume Ranking of Players (2025) 2.4 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Company (2021–2026) 2.5 Global Temperature Controlled Pharmaceutical Packaging Average Price by Company (2021–2026) 2.6 Key Manufacturers Temperature Controlled Pharmaceutical Packaging Manufacturing Base and Headquarters 2.7 Key Manufacturers Temperature Controlled Pharmaceutical Packaging Product Offerings 2.8 Key Manufacturers Start of Mass Production of Temperature Controlled Pharmaceutical Packaging 2.9 Temperature Controlled Pharmaceutical Packaging Market Competitive Analysis 2.9.1 Temperature Controlled Pharmaceutical Packaging Market Concentration Rate (2021–2026) 2.9.2 Global 5 and 10 Largest Manufacturers by Temperature Controlled Pharmaceutical Packaging Revenue in 2025 2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Temperature Controlled Pharmaceutical Packaging revenue, 2025 2.10 Mergers & Acquisitions and Expansion 3 Segmentation Temperature Controlled Pharmaceutical Packaging Market Classification 3.1 Introduction by Type 3.1.1 EPS material 3.1.2 PU material 3.1.3 VIP material 3.1.4 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Type 3.1.4.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Type (2021 vs 2025 vs 2032) 3.1.4.2 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Type (2021–2032) 3.1.4.3 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Type (%), 2021–2032 3.1.5 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Type 3.1.5.1 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Type (2021 vs 2025 vs 2032) 3.1.5.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Type (2021–2032) 3.1.5.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Type (%), 2021–2032 3.1.6 Global Temperature Controlled Pharmaceutical Packaging Average Price by Type (2021–2032) 3.2 Introduction by Usage Mode 3.2.1 Single use 3.2.2 Reusable 3.2.3 Other 3.2.4 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Usage Mode 3.2.4.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Usage Mode (2021 vs 2025 vs 2032) 3.2.4.2 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Usage Mode (2021–2032) 3.2.4.3 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Usage Mode (%), 2021–2032 3.2.5 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Usage Mode 3.2.5.1 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Usage Mode (2021 vs 2025 vs 2032) 3.2.5.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Usage Mode (2021–2032) 3.2.5.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Usage Mode (%), 2021–2032 3.2.6 Global Temperature Controlled Pharmaceutical Packaging Average Price by Usage Mode (2021–2032) 3.3 Introduction by Target Temperature 3.3.1 2–8°C Cold Chain 3.3.2 15–25°C Controlled Ambient 3.3.3 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Target Temperature 3.3.3.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Target Temperature (2021 vs 2025 vs 2032) 3.3.3.2 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Target Temperature (2021–2032) 3.3.3.3 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Target Temperature (%), 2021–2032 3.3.4 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Target Temperature 3.3.4.1 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Target Temperature (2021 vs 2025 vs 2032) 3.3.4.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Target Temperature (2021–2032) 3.3.4.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Target Temperature (%), 2021–2032 3.3.5 Global Temperature Controlled Pharmaceutical Packaging Average Price by Target Temperature (2021–2032) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Biopharmaceuticals 4.1.2 Vaccines 4.1.3 Others 4.2 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Application 4.2.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Application (2021 vs 2025 vs 2032) 4.2.2 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Application (2021–2032) 4.2.3 Global Temperature Controlled Pharmaceutical Packaging Sales Value, by Application (%), 2021–2032 4.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Application 4.3.1 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Application (2021 vs 2025 vs 2032) 4.3.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Application (2021–2032) 4.3.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume, by Application (%), 2021–2032 4.4 Global Temperature Controlled Pharmaceutical Packaging Average Price by Application (2021–2032) 5 Segmentation by Region 5.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Region 5.1.1 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Region: 2021 vs 2025 vs 2032 5.1.2 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Region (2021–2026) 5.1.3 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Region (2027–2032) 5.1.4 Global Temperature Controlled Pharmaceutical Packaging Sales Value by Region (%), 2021–2032 5.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Region 5.2.1 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Region: 2021 vs 2025 vs 2032 5.2.2 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Region (2021–2026) 5.2.3 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Region (2027–2032) 5.2.4 Global Temperature Controlled Pharmaceutical Packaging Sales Volume by Region (%), 2021–2032 5.3 Global Temperature Controlled Pharmaceutical Packaging Average Price by Region (2021–2032) 5.4 North America 5.4.1 North America Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 5.4.2 North America Temperature Controlled Pharmaceutical Packaging Sales Value by Country (%), 2025 vs 2032 5.5 Europe 5.5.1 Europe Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 5.5.2 Europe Temperature Controlled Pharmaceutical Packaging Sales Value by Country (%), 2025 vs 2032 5.6 Asia Pacific 5.6.1 Asia Pacific Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 5.6.2 Asia Pacific Temperature Controlled Pharmaceutical Packaging Sales Value by Region (%), 2025 vs 2032 5.7 South America 5.7.1 South America Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 5.7.2 South America Temperature Controlled Pharmaceutical Packaging Sales Value by Country (%), 2025 vs 2032 5.8 Middle East & Africa 5.8.1 Middle East & Africa Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 5.8.2 Middle East & Africa Temperature Controlled Pharmaceutical Packaging Sales Value by Country (%), 2025 vs 2032 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Temperature Controlled Pharmaceutical Packaging Sales Value Growth Trends, 2021 vs 2025 vs 2032 6.2 Key Countries/Regions Temperature Controlled Pharmaceutical Packaging Sales Value and Sales Volume 6.2.1 Key Countries/Regions Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.2.2 Key Countries/Regions Temperature Controlled Pharmaceutical Packaging Sales Volume, 2021–2032 6.3 United States 6.3.1 United States Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.3.2 United States Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.3.3 United States Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 6.4 Europe 6.4.1 Europe Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.4.2 Europe Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.4.3 Europe Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 6.5 China 6.5.1 China Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.5.2 China Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.5.3 China Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 6.6 Japan 6.6.1 Japan Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.6.2 Japan Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.6.3 Japan Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 6.7 South Korea 6.7.1 South Korea Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.7.2 South Korea Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.7.3 South Korea Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 6.8 Southeast Asia 6.8.1 Southeast Asia Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.8.2 Southeast Asia Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.8.3 Southeast Asia Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 6.9 India 6.9.1 India Temperature Controlled Pharmaceutical Packaging Sales Value, 2021–2032 6.9.2 India Temperature Controlled Pharmaceutical Packaging Sales Value by Type (%), 2025 vs 2032 6.9.3 India Temperature Controlled Pharmaceutical Packaging Sales Value by Application, 2025 vs 2032 7 Company Profiles 7.1 ThermoSafe 7.1.1 ThermoSafe Company Information 7.1.2 ThermoSafe Introduction and Business Overview 7.1.3 ThermoSafe Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.1.4 ThermoSafe Temperature Controlled Pharmaceutical Packaging Product Offerings 7.1.5 ThermoSafe Recent Developments 7.2 Envirotainer 7.2.1 Envirotainer Company Information 7.2.2 Envirotainer Introduction and Business Overview 7.2.3 Envirotainer Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.2.4 Envirotainer Temperature Controlled Pharmaceutical Packaging Product Offerings 7.2.5 Envirotainer Recent Developments 7.3 Pelican Biothermal 7.3.1 Pelican Biothermal Company Information 7.3.2 Pelican Biothermal Introduction and Business Overview 7.3.3 Pelican Biothermal Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.3.4 Pelican Biothermal Temperature Controlled Pharmaceutical Packaging Product Offerings 7.3.5 Pelican Biothermal Recent Developments 7.4 Cryopak 7.4.1 Cryopak Company Information 7.4.2 Cryopak Introduction and Business Overview 7.4.3 Cryopak Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.4.4 Cryopak Temperature Controlled Pharmaceutical Packaging Product Offerings 7.4.5 Cryopak Recent Developments 7.5 DS Smith Pharma 7.5.1 DS Smith Pharma Company Information 7.5.2 DS Smith Pharma Introduction and Business Overview 7.5.3 DS Smith Pharma Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.5.4 DS Smith Pharma Temperature Controlled Pharmaceutical Packaging Product Offerings 7.5.5 DS Smith Pharma Recent Developments 7.6 Cold Chain Technologies 7.6.1 Cold Chain Technologies Company Information 7.6.2 Cold Chain Technologies Introduction and Business Overview 7.6.3 Cold Chain Technologies Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.6.4 Cold Chain Technologies Temperature Controlled Pharmaceutical Packaging Product Offerings 7.6.5 Cold Chain Technologies Recent Developments 7.7 Intelsius 7.7.1 Intelsius Company Information 7.7.2 Intelsius Introduction and Business Overview 7.7.3 Intelsius Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.7.4 Intelsius Temperature Controlled Pharmaceutical Packaging Product Offerings 7.7.5 Intelsius Recent Developments 7.8 CSafe 7.8.1 CSafe Company Information 7.8.2 CSafe Introduction and Business Overview 7.8.3 CSafe Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.8.4 CSafe Temperature Controlled Pharmaceutical Packaging Product Offerings 7.8.5 CSafe Recent Developments 7.9 World Courier 7.9.1 World Courier Company Information 7.9.2 World Courier Introduction and Business Overview 7.9.3 World Courier Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.9.4 World Courier Temperature Controlled Pharmaceutical Packaging Product Offerings 7.9.5 World Courier Recent Developments 7.10 Sofrigam SA Ltd. 7.10.1 Sofrigam SA Ltd. Company Information 7.10.2 Sofrigam SA Ltd. Introduction and Business Overview 7.10.3 Sofrigam SA Ltd. Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.10.4 Sofrigam SA Ltd. Temperature Controlled Pharmaceutical Packaging Product Offerings 7.10.5 Sofrigam SA Ltd. Recent Developments 7.11 American Aerogel Corporation 7.11.1 American Aerogel Corporation Company Information 7.11.2 American Aerogel Corporation Introduction and Business Overview 7.11.3 American Aerogel Corporation Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.11.4 American Aerogel Corporation Temperature Controlled Pharmaceutical Packaging Product Offerings 7.11.5 American Aerogel Corporation Recent Developments 7.12 Aeris Group 7.12.1 Aeris Group Company Information 7.12.2 Aeris Group Introduction and Business Overview 7.12.3 Aeris Group Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.12.4 Aeris Group Temperature Controlled Pharmaceutical Packaging Product Offerings 7.12.5 Aeris Group Recent Developments 7.13 Inmark Packaging 7.13.1 Inmark Packaging Company Information 7.13.2 Inmark Packaging Introduction and Business Overview 7.13.3 Inmark Packaging Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.13.4 Inmark Packaging Temperature Controlled Pharmaceutical Packaging Product Offerings 7.13.5 Inmark Packaging Recent Developments 7.14 Saixin Cold Chain 7.14.1 Saixin Cold Chain Company Information 7.14.2 Saixin Cold Chain Introduction and Business Overview 7.14.3 Saixin Cold Chain Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.14.4 Saixin Cold Chain Temperature Controlled Pharmaceutical Packaging Product Offerings 7.14.5 Saixin Cold Chain Recent Developments 7.15 CIMC Cold Cloud 7.15.1 CIMC Cold Cloud Company Information 7.15.2 CIMC Cold Cloud Introduction and Business Overview 7.15.3 CIMC Cold Cloud Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.15.4 CIMC Cold Cloud Temperature Controlled Pharmaceutical Packaging Product Offerings 7.15.5 CIMC Cold Cloud Recent Developments 7.16 Minsate 7.16.1 Minsate Company Information 7.16.2 Minsate Introduction and Business Overview 7.16.3 Minsate Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.16.4 Minsate Temperature Controlled Pharmaceutical Packaging Product Offerings 7.16.5 Minsate Recent Developments 7.17 Beijing Youleng Cold Chain 7.17.1 Beijing Youleng Cold Chain Company Information 7.17.2 Beijing Youleng Cold Chain Introduction and Business Overview 7.17.3 Beijing Youleng Cold Chain Temperature Controlled Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2021–2026) 7.17.4 Beijing Youleng Cold Chain Temperature Controlled Pharmaceutical Packaging Product Offerings 7.17.5 Beijing Youleng Cold Chain Recent Developments 8 Industry Chain Analysis 8.1 Temperature Controlled Pharmaceutical Packaging Industrial Chain 8.2 Temperature Controlled Pharmaceutical Packaging Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Key Suppliers of Raw Materials 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customer Analysis) 8.5 Sales Model and Sales Channelss 8.5.1 Temperature Controlled Pharmaceutical Packaging Sales Model 8.5.2 Sales Channels 8.5.3 Temperature Controlled Pharmaceutical Packaging Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（ケミカル）の最新刊レポート
QYResearch社の 包装材分野 での最新刊レポート
本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
